190 related articles for article (PubMed ID: 22155918)
1. High prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression.
Kanjanavanit S; Puthanakit T; Vibol U; Kosalaraksa P; Hansudewechakul R; Ngampiyasakul C; Wongsawat J; Luesomboon W; Wongsabut J; Mahanontharit A; Suwanlerk T; Saphonn V; Ananworanich J; Ruxrungtham K;
Antivir Ther; 2011; 16(8):1351-5. PubMed ID: 22155918
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
3. Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
Musiime V; Cook A; Kayiwa J; Zangata D; Nansubuga C; Arach B; Kenny J; Wavamunno P; Komunyena J; Kabamba D; Asiimwe AR; Mirembe G; Abongomera G; Mulenga V; Kekitiinwa A; Kityo C; Walker SA; Klein N; Gibb DM;
Antivir Ther; 2014; 19(3):269-76. PubMed ID: 24717427
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
Estrada V; Geijo P; Fuentes-Ferrer M; Alcalde ML; Rodrigo M; Galindo MJ; Muñoz A; Domingo P; Ribera E; Cosín J; Viciana P; Lozano F; Terrón A; Vergara A; Teira R; Muñoz-Sánchez J; Roca B; Sánchez T; López-Aldeguer J; Deig E; Vidal F; Pedrol E; Castaño-Carracedo M; Puig T; Garrido M; Suárez-Lozano I
BMC Womens Health; 2011 Aug; 11():36. PubMed ID: 21816091
[TBL] [Abstract][Full Text] [Related]
5. High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy.
Innes S; Abdullah KL; Haubrich R; Cotton MF; Browne SH
Pediatr Infect Dis J; 2016 Jan; 35(1):e1-7. PubMed ID: 26421804
[TBL] [Abstract][Full Text] [Related]
6. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.
Bekolo CE; Nguena MB; Ewane L; Bekoule PS; Kollo B
BMC Public Health; 2014 Mar; 14():236. PubMed ID: 24606888
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria--Implications for Care.
Kuti MA; Adesina OA; Awolude OA; Ogunbosi BO; Fayemiwo SA; Akinyemi JO; Adetunji AA; Irabor AE; Odaibo GN; Prosper O; Taiwo BO; Olaleye D; Murphy RL; Kanki P; Adewole IF
J Int Assoc Provid AIDS Care; 2015; 14(4):355-9. PubMed ID: 25331224
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
9. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
[TBL] [Abstract][Full Text] [Related]
10. The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.
Liu S; Wei B; Liang W; Chen T; Deng L; Zhao M; Wan J
Front Public Health; 2023; 11():1161503. PubMed ID: 37181701
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of anemia and underlying iron status in naive antiretroviral therapy HIV-infected children with moderate immune suppression.
Kosalaraksa P; Bunupuradah T; Vonthanak S; Wiangnon S; Hansudewechakul R; Vibol U; Kanjanavanit S; Ngampiyaskul C; Wongsawat J; Luesomboon W; Lumbiganon P; Sopa B; Apornpong T; Chuenyam T; Cooper DA; Ruxrungtham K; Ananworanich J; Puthanakit T
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1679-86. PubMed ID: 22734817
[TBL] [Abstract][Full Text] [Related]
12. Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.
Echeverría P; Bonjoch A; Puig J; Ornella A; Clotet B; Negredo E
HIV Med; 2017 Nov; 18(10):782-786. PubMed ID: 28671337
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India.
Padmapriyadarsini C; Ramesh Kumar S; Terrin N; Narendran G; Menon PA; Ramachandran G; Subramanyan S; Venkatesan P; Wanke C; Swaminathan S
Clin Infect Dis; 2011 Feb; 52(4):540-6. PubMed ID: 21252141
[TBL] [Abstract][Full Text] [Related]
14. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.
Chantry CJ; Hughes MD; Alvero C; Cervia JS; Meyer WA; Hodge J; Borum P; Moye J;
Pediatrics; 2008 Jul; 122(1):e129-38. PubMed ID: 18519448
[TBL] [Abstract][Full Text] [Related]
15. Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia.
Taramasso L; Di Biagio A; Riccardi N; Briano F; Di Filippo E; Comi L; Mora S; Giacomini M; Gori A; Maggiolo F
PLoS One; 2019; 14(10):e0223181. PubMed ID: 31603906
[TBL] [Abstract][Full Text] [Related]
16. Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy.
Mankhatitham W; Luaengniyomkul A; Manosuthi W
J Med Assoc Thai; 2012 Feb; 95(2):163-9. PubMed ID: 22435244
[TBL] [Abstract][Full Text] [Related]
17. Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, Tanzania.
Armstrong C; Liu E; Okuma J; Spiegelman D; Guerino C; Njelekela M; Grinspoon S; Fawzi W; Hawkins C
J Acquir Immune Defic Syndr; 2011 Jun; 57(2):141-5. PubMed ID: 21436713
[TBL] [Abstract][Full Text] [Related]
18. Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study.
Wongprikorn A; Sukasem C; Puangpetch A; Numthavej P; Thakkinstian A; Kiertiburanakul S
PLoS One; 2016; 11(6):e0157531. PubMed ID: 27304841
[TBL] [Abstract][Full Text] [Related]
19. Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan.
Oka F; Naito T; Oike M; Imai R; Saita M; Inui A; Mitsuhashi K; Isonuma H; Shimbo T
J Infect Chemother; 2012 Feb; 18(1):17-21. PubMed ID: 21735099
[TBL] [Abstract][Full Text] [Related]
20. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
